Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. (Q42985436)

12 November 2017

title

Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

Cinthia B Drachenberg

6

object named as

Cinthia Drachenberg

1 reference

12 November 2017

5

John Papadimitriou

1 reference

12 November 2017

Kester Crosse

1

1 reference

12 November 2017

Onuora G Umeadi

2

1 reference

12 November 2017

Frank A Anania

3

1 reference

12 November 2017

Jacqueline Laurin

4

1 reference

12 November 2017

Charles D Howell

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Clinical Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

2

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

463-468

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Risk factors for the rising rates of primary liver cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Outcome of hospital care of liver disease associated with hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Hepatitis C, iron status, and disease severity: relationship with HFE mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

A comparison of dietary trends among racial and socioeconomic groups in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Correlates of hepatitis C virus infections among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900162-4

7 January 2021

10.1016/S1542-3565(04)00162-4

Identifiers

DOI

1 reference

12 November 2017

1 reference